2012
DOI: 10.1002/anie.201204645
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Expressed GPCR Inserted in Polymersome Membranes for Ligand‐Binding Studies

Abstract: The dopamine receptor D2 (DRD2), a G-protein coupled receptor is expressed into PBd(22)-PEO(13) and PMOXA(20)-PDMS(54)-PMOXA(20) block copolymer vesicles. The conformational integrity of the receptor is confirmed by antibody- and ligand-binding assays. Replacement of bound dopamine is demonstrated on surface-immobilized polymersomes, thus making this a promising platform for drug screening.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
45
1
3

Year Published

2013
2013
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(50 citation statements)
references
References 26 publications
0
45
1
3
Order By: Relevance
“…Later, selective deposition and self‐assembly of triblock copolymers (polymethyloxazoline‐polydimethylsiloxane‐polymethyloxazoline [PMOXA‐PDMS‐PMOXA], (ABA)) were demonstrated for fabrication of matrix arrays for dopamine receptor 2 (DRD2) membrane protein expression, producing membrane protein array for diagnostics or drug discovery purposes (Andreasson‐Ochsner et al, 2012). Likewise, production and integration of DRD2 into PMOXA (20) –PDMS (54) –PMOXA (20) and PBd (22) –PEO (13) block copolymer vesicles are used for ligand‐ and antibody‐binding assays (Figure 7e; May et al, 2013). Very recently, diblock copolymers of poly (ethylene oxide)‐b‐poly(butadiene) PEO‐b‐PBD is exploited to enhance folding of a mechanosensitive channel of large conductance membrane protein during cell‐free expression (Jacobs, Boyd, & Kamat, 2019).…”
Section: Cfps: Latest Platforms and Applications In Biotechnology Andmentioning
confidence: 99%
“…Later, selective deposition and self‐assembly of triblock copolymers (polymethyloxazoline‐polydimethylsiloxane‐polymethyloxazoline [PMOXA‐PDMS‐PMOXA], (ABA)) were demonstrated for fabrication of matrix arrays for dopamine receptor 2 (DRD2) membrane protein expression, producing membrane protein array for diagnostics or drug discovery purposes (Andreasson‐Ochsner et al, 2012). Likewise, production and integration of DRD2 into PMOXA (20) –PDMS (54) –PMOXA (20) and PBd (22) –PEO (13) block copolymer vesicles are used for ligand‐ and antibody‐binding assays (Figure 7e; May et al, 2013). Very recently, diblock copolymers of poly (ethylene oxide)‐b‐poly(butadiene) PEO‐b‐PBD is exploited to enhance folding of a mechanosensitive channel of large conductance membrane protein during cell‐free expression (Jacobs, Boyd, & Kamat, 2019).…”
Section: Cfps: Latest Platforms and Applications In Biotechnology Andmentioning
confidence: 99%
“…Incorporation of GPCRs into polymersomes via cell free expression has been previously demonstrated. In 2013, May et al incorporated the dopamine receptor D 2 (DRD2) into polymeric vesicles . However, they only observed ligand binding on nanoscale vesicles and were not able to show functionality since the G proteins were not present.…”
Section: ‐Ht1ar In Pgup Response To Changes In Antagonist Species Anmentioning
confidence: 99%
“…Alternatively, reconstitution of membrane proteins into lipid membranes results in a random distribution and reduced accessibility to ligands [14,15]. Currently, cell-free approaches showed the expression and co-translational insertion of GPCRs directly into a lipid bilayer [16,17], in "nanodiscs" which are discoidal phospholipid bilayers stabilized by amphiphilic helical membrane proteins [18] or even in amphiphilic block-copolymer membranes [19]. In terms of the cotranslational insertion into lipid bilayers or liposomes, a unidirectional orientation of the GPCR molecules in the membrane structure is observed, since the protein synthesis machinery is added to the exposed plane of the bilayer membrane surface [20].…”
Section: Introductionmentioning
confidence: 99%